Survival time after surgery in patients with renal cell carcinoma

The treatment of cancer patients fear most pessimistic, a group of patients, once identified renal cell carcinoma, they spook desperate to die, speculating that his energy Huoduo Jiu, which largely reduced the survival of cancer patients, on the contrary, Patients with positive attitude and correct the face of cancer, actively cooperate with the treatment, this is the nature of cancer patients can live to the age of magic weapons. Therefore, in patients with renal cell carcinoma after surgery should maintain a good attitude, good postoperative rehabilitation care, can significantly extend their lives.

Renal cell carcinoma is a cancer of a better prognosis, its surgical treatment was very good. Then the renal cell carcinoma after surgery can Huoduo Jiu? Depends on whether the early stage, when the kidney cancer is still confined to Renal postoperative 5-year survival rate at 60-80%, renal cell carcinoma distant metastasis, the postoperative survival rate is roughly 3 years, 50%, 5-year 40%, 10 years 20%.

Renal cancer patients affected by various factors can Huo Duojiu impact of patient illness, physical condition, psychological and other aspects of differences can not be generalized, but the overall trend is good. Postoperative renal cell survival to a certain extent with the patient's physical functions related to bodily functions is good, strong immunity, such as consolidation therapy after receiving traditional Chinese medicine in order to resist the development of cancer and reduce recurrence. We should know that renal cell carcinoma recurrence after five years is the peak period, once the relapse, treatment on the difficulties and poor prognosis.

With regard to experts pointed out that, in order to better prevent the recurrence of the emergence of radical surgery for renal cell carcinoma In addition to Chinese medicine treatment can be carried out after the biological treatment, drugs used are: interferon and IL-2, doses of 1 million, 300 million, 600 million units, usage, and express their views with the volume, did not reach unity. But in the end whether to adopt but also according to the patients as well as the economic conditions will be selected